Compound details
Sesamolinol
| Compound ID | CDAMM00158 |
|---|---|
| Common name | Sesamolinol | IUPAC name | 4-[[(3S,3aR,6R,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]oxy]-2-methoxyphenol |
| Molecular formula | C20H20O7 |
| Retention time | 52.02 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 373.129 | Theoretical mz | 373.128 |
| Error | 1.68 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.842 |
| Inchi key | OJVGWDJIYBTWDS-UHFFFAOYNA-N |
|---|---|
| Smiles | COC1=C(C=CC(=C1)OC2C3COC(C3CO2)C4=CC5=C(C=C4)OCO5)O |
| Superclass | Benzenoids |
| Class | Phenols |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SEA |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| Q8N183 | NDUFAF2 | HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2 | T01453 | SEA |
| Q9P0J0 | NDUFA13 | Mitochondrial complex I | T82391 | SEA |
| Q9Y6M9 | NDUFB9 | HUMAN NADH:ubiquinone oxidoreductase subunit B9 | T01465 | SEA |
| Q8N183 | NDUFAF2 | HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2 | T01453 | SEA |
| P03897 | MT-ND3 | NADH dehydrogenase | T77195 | SEA |
| Q02880 | TOP2B | DNA topoisomerase II beta | T85733 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T82391 | DI0069 | Cardiomyopathy | [ICD-11: BC43] | Q9P0J0 | NDUFA13 |
| T77195 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P03897 | MT-ND3 |
| T85733 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q02880 | TOP2B |
| T85733 | DI0076 | Chemoprotection | [ICD-11: N.A.] | Q02880 | TOP2B |